Insider Trading disclosures for iBio Inc
The latest disclosure was made by B. Brenner Martin in iBio Inc where a trade of 230,700
Stock Option (right to buy) done
was reported to US exchanges on Feb. 21, 2025.
Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Client Name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Security Type |
|
B. Brenner Martin
|
Director, See Remarks |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Feb 2025 |
230,700 |
230,700
|
-
|
|
-
|
Stock Option (right to buy) |
|
Banjak Marc
|
Chief Legal Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Feb 2025 |
71,000 |
71,000
|
-
|
|
-
|
Stock Option (right to buy) |
|
Duran Felipe
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Feb 2025 |
84,700 |
84,700
|
-
|
|
-
|
Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges